Home|Best-Bschool-in-india-2018

DSIJ Mindshare

Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher

Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher

Rishikesh Gaikwad 0 1894 Article rating: 3.4

Cipla Limited today announced that it has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg, and 120mg/240mg starter pack from United States Food & Drug Administration (USFDA).

Read more
Tata Elxsi opens Global Engineering Centre with Schaeffler Technologies Tata Elxsi opens Global Engineering Centre with Schaeffler Technologies

Tata Elxsi opens Global Engineering Centre with Schaeffler Technologies

Rishikesh Gaikwad 0 1354 Article rating: 3.8

Tata Elxsi, a global design and technology services company, announced the opening of a Global Engineering Centre (GEC) with Schaeffler Technologies AG & Co. KG, a world leader in providing mechatronics solutions for the transportation industry. Schaeffler Group is a global supplier to the automotive and industrial sectors.

Read more
SPARC grants exclusive license to Tripoint Therapeutics to commercialise Epilepsy tablets in USA SPARC grants exclusive license to Tripoint Therapeutics to commercialise Epilepsy tablets in USA

SPARC grants exclusive license to Tripoint Therapeutics to commercialise Epilepsy tablets in USA

Rishikesh Gaikwad 0 802 Article rating: 5.0

Sun Pharma Advanced Research Company Ltd (SPARC) today announced the grant of an exclusive license to Tripoint Therapeutics LLC, USA (Tripoint) to commercialise ElepsiaTM XR 1,000 mg and ElepsiaTM XR 1,500 mg tablets in the USA.

Read more
RSS
123578910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList